Turning Point Benefit Group’s Clorox CLX Stock Holding History

Turning Point Benefit Group’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17	Closed	-$1.71K	–	229
2025 Q4	$1.71K	Buy	+17	New	+$1.85K	﹤0.01%	470

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Turning Point Benefit Group's CLX Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Clorox (CLX) in Q1 2026, closing a stake of 17 shares — an estimated $1.71K sold.

Turning Point Benefit Group first reported a position in CLX in Q4 2025 and held it in 1 quarter. The position peaked at $1.71K in Q4 2025. 1,089 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

Turning Point Benefit Group reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
Turning Point Benefit Group sold 17 Clorox shares in Q1 2026, an estimated $1.71K.
Turning Point Benefit Group first reported a position in Clorox in Q4 2025 and held it in 1 quarter.
Turning Point Benefit Group's Clorox position peaked at $1.71K in Q4 2025.
1,089 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.